InvestorsHub Logo
icon url

jq1234

09/12/12 12:12 PM

#148701 RE: DewDiligence #148698

OK. Thanks. They didn't explain that well at all in PR. I thought they weren't going to enroll patients in stage 2 until they had result from stage 1.
icon url

vinmantoo

09/12/12 12:38 PM

#148708 RE: DewDiligence #148698

""ONCY—The additional 80 patients are those who were enrolled in the second stage of the original study, which has now been superseded by a bifurcated redo of the first stage of the study.""

Hence, a significant delay and the stock drops. I like a post that uses the word bifurcated, but like it more that it doesn't refer to bad news about a stock I do own.
icon url

pcrutch

09/12/12 12:58 PM

#148712 RE: DewDiligence #148698

Very odd and suggests a good amount of gross misconduct on their part. The study failed and then they decided to use these extra patients to re-do stage 1? Gimme a break.
icon url

DewDiligence

12/13/12 11:56 AM

#154030 RE: DewDiligence #148698

ONCY reports successful phase-3 results in H&N cancer—or did it? Here’s the PR:

http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-positive-113000061.html